These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2106 related articles for article (PubMed ID: 27126487)

  • 1. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
    Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
    Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing PMTCT service delivery in rural North-Central Nigeria: protocol and design for a cluster randomized study.
    Aliyu MH; Blevins M; Audet C; Shepherd BE; Hassan A; Onwujekwe O; Gebi UI; Kalish M; Lindegren ML; Vermund SH; Wester CW
    Contemp Clin Trials; 2013 Sep; 36(1):187-97. PubMed ID: 23816493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya.
    Odeny TA; Hughes JP; Bukusi EA; Akama E; Geng EH; Holmes KK; McClelland RS
    PLoS Med; 2019 Oct; 16(10):e1002924. PubMed ID: 31577792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
    Tudor Car L; van-Velthoven MH; Brusamento S; Elmoniry H; Car J; Majeed A; Atun R
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008741. PubMed ID: 21678382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Enhanced Mentor Mother ProgrAm (EMMA) for the prevention of mother-to-child transmission of HIV in Kenya: study protocol for a cluster randomized controlled trial.
    Larson BA; Bii M; Tsikhutsu I; Halim N; Wolfman V; Coakley P; Sugut W; Sawe F
    Trials; 2018 Oct; 19(1):594. PubMed ID: 30376872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
    Onah HE; Ibeziako N; Nkwo PO; Obi SN; Nwankwo TO
    J Obstet Gynaecol; 2008 Apr; 28(3):276-9. PubMed ID: 18569467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
    Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
    J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missed Opportunities along the Prevention of Mother-to-Child Transmission Services Cascade in South Africa: Uptake, Determinants, and Attributable Risk (the SAPMTCTE).
    Woldesenbet S; Jackson D; Lombard C; Dinh TH; Puren A; Sherman G; Ramokolo V; Doherty T; Mogashoa M; Bhardwaj S; Chopra M; Shaffer N; Pillay Y; Goga A;
    PLoS One; 2015; 10(7):e0132425. PubMed ID: 26147598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional cash transfers to prevent mother-to-child transmission in low facility-delivery settings: evidence from a randomised controlled trial in Nigeria.
    Liu JX; Shen J; Wilson N; Janumpalli S; Stadler P; Padian N
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):32. PubMed ID: 30651080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cluster randomized controlled trial of lay health worker support for prevention of mother to child transmission of HIV (PMTCT) in South Africa.
    Peltzer K; Weiss SM; Soni M; Lee TK; Rodriguez VJ; Cook R; Alcaide ML; Setswe G; Jones DL
    AIDS Res Ther; 2017 Dec; 14(1):61. PubMed ID: 29248014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.
    Rawizza HE; Chang CA; Chaplin B; Ahmed IA; Meloni ST; Oyebode T; Banigbe B; Sagay AS; Adewole IF; Okonkwo P; Kanki PJ;
    Curr HIV Res; 2015; 13(3):201-9. PubMed ID: 25986371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
    Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
    Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional cash transfers and uptake of and retention in prevention of mother-to-child HIV transmission care: a randomised controlled trial.
    Yotebieng M; Thirumurthy H; Moracco KE; Kawende B; Chalachala JL; Wenzi LK; Ravelomanana NL; Edmonds A; Thompson D; Okitolonda EW; Behets F
    Lancet HIV; 2016 Feb; 3(2):e85-93. PubMed ID: 26847230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV status disclosure, facility-based delivery and postpartum retention of mothers in a prevention clinical trial in rural Nigeria.
    Sarko KA; Blevins M; Ahonkhai AA; Audet CM; Moon TD; Gebi UI; Gana AM; Wester CW; Vermund SH; Aliyu MH
    Int Health; 2017 Jul; 9(4):243-251. PubMed ID: 28810669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 106.